InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the complete record of transactions filed by Jorden David Emerson, 首席财务官. Director active across 1 company, notably Nuo Therapeutics, Inc.. In total, 9 disclosures have been recorded. Breakdown: 2 buys · 2 sells. Total volume traded: €311k. History available since 29 April 2022. The latest transaction was disclosed on 27 August 2026 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 条申报中的 9 条
JORDEN DAVID EMERSON is Président-Directeur Financier at Nuo Therapeutics, Inc. (XNAS), where the listed role is CEO/CFO. He has 7 filings in total, and across the sampled recent filings the transactions run from 2022-05-02 to 2026-08-28, with 0 EUR of buys and 303263 EUR of sells; the modal transaction nature is Attribution.